1,030 reports of this reaction
3.7% of all OMEGA 3 ACID ETHYL ESTERS reports
#1 most reported adverse reaction
FLUSHING is the #1 most commonly reported adverse reaction for OMEGA 3 ACID ETHYL ESTERS, manufactured by Waylis Therapeutics LLC. There are 1,030 FDA adverse event reports linking OMEGA 3 ACID ETHYL ESTERS to FLUSHING. This represents approximately 3.7% of all 27,867 adverse event reports for this drug.
Patients taking OMEGA 3 ACID ETHYL ESTERS who experience flushing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FLUSHING is moderately reported among OMEGA 3 ACID ETHYL ESTERS users, representing a notable but not dominant share of adverse events.
In addition to flushing, the following adverse reactions have been reported for OMEGA 3 ACID ETHYL ESTERS:
The following drugs have also been linked to flushing in FDA adverse event reports:
FLUSHING has been reported as an adverse event in 1,030 FDA reports for OMEGA 3 ACID ETHYL ESTERS. This does not prove causation, but indicates an association observed in post-market surveillance data.
FLUSHING accounts for approximately 3.7% of all adverse event reports for OMEGA 3 ACID ETHYL ESTERS, making it one of the most commonly reported side effect.
If you experience flushing while taking OMEGA 3 ACID ETHYL ESTERS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.